Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells
Somya Ranjan Dash, Subhajit Chatterjee, Saptarshi Sinha, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 40, pp. 102502-102502
Closed Access | Times Cited: 18

Showing 18 citing articles:

Advanced drug delivery platforms target cancer stem cells
MirAhmad Mazloomi, Abolfazl Doustmihan, Sajjad Alimohammadvand, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101036-101036
Open Access | Times Cited: 3
Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway
Rajalaxmi Pradhan, Subarno Paul, Biswajit Das, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 113, pp. 109257-109257
Closed Access | Times Cited: 32
Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells
Biswajit Das, Somya Ranjan Dash, Harun Patel, et al.
Phytomedicine (2023) Vol. 117, pp. 154914-154914
Closed Access | Times Cited: 16
Near-Infrared Enhances Antiangiogenic Potentiality of Quinacrine-Gold Hybrid Nanoparticles in Breast Cancer Stem Cells Via Deregulation of HSP-70/TGF-β
Somya Ranjan Dash, Biswajit Das, Chinmay Das, et al.
Nanomedicine (2023) Vol. 18, Iss. 1, pp. 19-33
Closed Access | Times Cited: 11
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation
Saptarshi Sinha, Subarno Paul, S. Acharya, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 4
Resveratrol nanoparticles induce apoptosis in oral cancer stem cells by disrupting the interaction between β-catenin and GLI-1 through p53-independent activation of p21
Subhasmita Bhal, Biswajit Das, Saptarshi Sinha, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access | Times Cited: 4
Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway
Saptarshi Sinha, Subhajit Chatterjee, Subarno Paul, et al.
Experimental Cell Research (2022) Vol. 420, Iss. 1, pp. 113338-113338
Closed Access | Times Cited: 18
Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A
Deepika Nayak, Subarno Paul, Chinmay Das, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 609-626
Open Access | Times Cited: 18
Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping
Subhajit Chatterjee, Ajit Kumar Dhal, Subarno Paul, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 12, pp. 3521-3535
Closed Access | Times Cited: 15
Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
Subarno Paul, Subhajit Chatterjee, Saptarshi Sinha, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 999-1015
Closed Access | Times Cited: 9
Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300
Chinmay Das, Somya Ranjan Dash, Saptarshi Sinha, et al.
Medical Oncology (2023) Vol. 40, Iss. 12
Open Access | Times Cited: 8
Roles of Mitochondria in Oral Squamous Cell Carcinoma Therapy: Friend or Foe?
Junqiang Bai, Luping Wu, Xinmiao Wang, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5723-5723
Open Access | Times Cited: 13
Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells
Biswajit Das, Chinmayee Sethy, Subhajit Chatterjee, et al.
Journal of Cell Communication and Signaling (2023) Vol. 17, Iss. 4, pp. 1371-1388
Open Access | Times Cited: 5
Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agents
Vajja Krishna Rao, Subarno Paul, Mitchell Gulkis, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 3, pp. 937-962
Closed Access | Times Cited: 1
Nanotechnology at the Crossroads of Stem Cell Medicine
Sweny Jain, Jay Bhatt, Sharad Gupta, et al.
Biomaterials Science (2024)
Closed Access
Near Infrared-Responsive Quinacrine–Gold Hybrid Nanoparticles Deregulate HSP-70/P300-Mediated H3K14 Acetylation in ER/PR+ Breast Cancer Stem Cells
Somya Ranjan Dash, Chinmay Das, Biswajit Das, et al.
Nanomedicine (2024) Vol. 19, Iss. 7, pp. 581-596
Closed Access
Talazoparib enhances the Quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300
Chinmay Das, Somya Ranjan Dash, Saptarshi Sinha, et al.
Research Square (Research Square) (2023)
Open Access
Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells
Biswajit Das, Chinmayee Sethy, Subhajit Chatterjee, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top